burden of the central nervous system malignancies in iran 2003

abstract objective : the policy makers and social managers need some criteria for building up the appropriate health status of the community and observe the equity and equality on it. they have to know the burden of diseases as a main determining factor for decision making, planning and programming. disability adjusted life years (dalys) is a criteria which shows the wasted life time due to early death and also wasted time due to disease morbidity and disability. central nervous system malignancies are important especially in children and estimating the burden of these malignancies in iran will enable the health policy makers to share the community sources, as appropriate. material and methods : the estimation of burden of disease and risk factors was a national study that began on 2003 by the ministry of health and medical education (moh&me;) after establishing cancer registry in the country. here by we discussed about the burden of cns malignancies as a part of this study. this study was performed by a special modelling and new software.   results : due to wasted life time of early death and morbidity, cns malignancies are the third malignancy in iran. year waste in iranian population is 0.69 in each 1000 person. keywords : cns malignancies, burden of disease, dalys, iran please cite this article as: zali ar, abolhassani f, khayamzadeh m, moradi lake m, jamali a, salmanian r, et al. burden of the central nervous system malignancies in iran 2003. iran j cancer prev. 2008; 1(1): 6-11. references: 1. world health organization, how is public interest protected, in world health report 2000; health system: improving performance, 2000 2. murray cjl, acharya ak. understanding dalys. j health economics. 1997 3. murray cjl, lopez, ad, eds. the global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. global burden of disease and injury series, vol. 1. cambridge: harvard university press; 1996. 4. naghavi m, abolhassani f, moradi lake m, etc. guideline for estimation the burden of disease, moh&me;, tehran, 2005. 5. brunicardi fc, andersen dk, billiar tr, dunn dl, hunterjg, pollock re, schwartz's principles of surgery, 8/e, mcgraw-hill professional; 8th edition, october 14, 2004 6. kasperdl, braunwald e, fauci a, hausers, longo d, jameson jl, harrison's principles of internal medicine, 16th edition, mcgraw-hill professional, july 23, 2004 7. goldman l, ausiello d, cecil textbook of medicine, 22th edition, w.b. saunders company; 22th edition , december 2003 8. mathers c, lopez a, cancer incidence, mortality and survival site for 14 regions of the world, who, 2001. 9. naghavi m, death registry in 23 province in iran, forth book, moh&me;, tehran, 2005. 10. seer cancer statistics review 1975-2002, central nervous system cancers (table xiv-5), (the national cancer institute of u.s.), http:// seer.cancer.gov /csr/ 1975_2003/sections.html 11. department of human services of australia, burden of disease http:// www.health.vic.gov.au /healthstatus/ bod/ daly.htm 12. incidence, prevalence, mortality, yll, yld and dalys by sex, cause and who region, estimates for 2002 as reported in the